Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.50 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | ADH1B | P00325 | 1/20 | 0.41 |
| ▸ | ADH1C | P00326 | 1/20 | 0.41 |
| ▸ | ADH1A | P07327 | 1/20 | 0.41 |
| ▸ | ADH4 | P08319 | 1/20 | 0.41 |
| ▸ | ADH7 | P40394 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 4/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | BIRC2 | Q13490 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21049824 | 0.85 | ZDHHC7 (0.53) | ZDHHC7ABCB1CA1ADH1BADH1C | |
| SCHEMBL12693570 | 0.85 | ZDHHC7 (0.45) | ZDHHC7ABCB1CA1FAAHACE2 | |
| SCHEMBL15913628 | 0.81 | ZDHHC7 (0.43) | ZDHHC7ABCB1CA1ADH1BADH1C | |
| SCHEMBL28579233 | 0.80 | EP300 (0.50) | ZDHHC7CA1ACE2LMNAGPR84 | |
| SCHEMBL20205672 | 0.78 | GLO1 (0.50) | ZDHHC7ABCB1CA1FAAHACE2 | |
| SCHEMBL3915573 | 0.78 | GLO1 (0.50) | ZDHHC7ABCB1CA1FAAHACE2 | |
| SCHEMBL3915569 | 0.78 | GLO1 (0.50) | ZDHHC7ABCB1CA1FAAHACE2 | |
| SCHEMBL20205354 | 0.78 | LMNA (0.44) | ZDHHC7ABCB1CA1FAAHCNR1 | |
| SCHEMBL15913978 | 0.77 | MEN1 (0.35) | CA1CA2 | |
| SCHEMBL4011240 | 0.77 | TSHR (0.34) | CA1CA2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190276387-A1 | PRECURSOR COMPOUNDS FOR FRAGRANT ALDEHYDES | GIVAUDAN SA (CH) | 2019-09-12 | — | — | US | disclosed |
| WO-2018096176-A1 | PRECURSOR COMPOUNDS FOR FRAGRANT ALDEHYDES | GIVAUDAN SA (CH) | 2018-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190276387-A1 | PRECURSOR COMPOUNDS FOR FRAGRANT ALDEHYDES | HAAO, B3GNT2, NAA40 | ZDHHC7 251/4885ABCB1 4643/4885CA1 1292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.